Skip to content

Clinical trials

Phase 3 Hepatitis B trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Phase: Phase 3 Country / region: United States Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20044
20052
20062
20073
20083
20091
20101
20123
20142
20173
20202
20211
20222
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated7
Active, not recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences5
GlaxoSmithKline4
Dynavax Technologies Corporation3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)3
Bristol-Myers Squibb2
National Institute of Allergy and Infectious Diseases (NIAID)2
Novartis2
Pharmasset2
VBI Vaccines Inc.2
HIV Prevention Trials Network1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B32
Hepatitis B, Chronic10
HIV Infections5
Hepatitis5
Hepatitis, Chronic4
Acquired Immunodeficiency Syndrome2
Hepatitis C2
Chronic Disease1
Diphtheria1
Fibrosis1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.